Category - CDC
FDA Fails to Provide Credible Data and Science to Justify Scheduling Kratom as Schedule I Substance
Kratom Draws Support And Controversy As Opioid Addiction Treatment
Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary Medicine Stephen Ostroff, M.D., on the ongoing risk of salmonella in kratom products
